FULBRIGHT & JAWORSKI L.L.P. A Registered Limited Liability Partnership 666 Fifth Avenue, 31st Floor New York, New York 10103-3198 www.fulbright.comPlacement Agency Agreement • January 26th, 2005 • Vion Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 26th, 2005 Company IndustryReference is made to the Placement Agency Agreement, dated January 25, 2005 (the "Agency Agreement"), by and among the Company and CIBC World Markets Corp. and Leerink Swann & Company, as placement agents, and the form of purchase agreements (the "Purchase Agreement") with each investor in connection with the offering. We have acted as counsel to the Company in connection with the purchase by certain investors (the "Investors") of an aggregate of 10,000,000 shares (the "Shares") of the Company's common stock, $.01 par value per share (the "Common Stock"). A prospectus supplement, dated January 26, 2005, has been filed under Rule 424(b)(5) of the Securities Act of 1933, as amended (the "Act"), with respect to the sale of the Shares, to the prospectus dated January 10, 2004 which was part of a Registration Statement on Form S-3 (Registration No. 333-121251), as amended, which became effective under the Act on January 10, 2005.
W I T N E S S E T H:Placement Agency Agreement • November 4th, 2003 • Stonepath Group Inc • Arrangement of transportation of freight & cargo • Texas
Contract Type FiledNovember 4th, 2003 Company Industry Jurisdiction
December 22, 1999 C3D Inc. 230 Park Avenue, Suite 453 New York, NY 10169 Attn: Eugene Levich President and CEO Re: Amendment No. 1 to Placement Agency Agreement --------------------------------------------- Dear Dr. Levich: The parties hereto, C3D...Placement Agency Agreement • January 14th, 2000 • C3d Inc • Services-prepackaged software
Contract Type FiledJanuary 14th, 2000 Company Industry